There is provided a pharmaceutical composition suitable for topical administration to an eye, the composition comprising (a) a pharmacologically effective concentration of an active agent and (b) a combination of at least two ophthalmically compatible polymers comprising a novel gum system. In preferred...http://www.google.fr/patents/US20030232089?utm_source=gb-gplus-shareBrevet US20030232089 - Ophthalmic formulation with novel gum composition
Numéro de demande: 10/370,220 Numéro de publication: US 2003/0232089 A1 Date de dépôt: 20 févr. 2003 Brevet délivré: US7128928 ( Date de délivrance 31 oct. 2006)
